Transcriptional enhancers are non-coding segments of DNA that play a central role in the spatiotemporal regulation of gene expression programs. However, systematically and precisely predicting enhancers remain a major challenge. Although existing methods have achieved some success in enhancer prediction, they still suffer from many issues. We developed a deep learning-based algorithmic framework named PEDLA (https://github.com/wenjiegroup/PEDLA), which can directly learn an enhancer predictor from massively heterogeneous data and generalize in ways that are mostly consistent across various cell types/tissues. We first trained PEDLA with 1,114-dimensional heterogeneous features in H1 cells, and demonstrated that PEDLA framework integrates diverse heterogeneous features and gives state-of-the-art performance relative to five existing methods for enhancer prediction. We further extended PEDLA to iteratively learn from 22 training cell types/tissues. Our results showed that PEDLA manifested superior performance consistency in both training and independent test sets. On average, PEDLA achieved 95.0% accuracy and a 96.8% geometric mean (GM) across 22 training cell types/tissues, as well as 95.7% accuracy and a 96.8% GM across 20 independent test cell types/tissues. Together, our work illustrates the power of harnessing state-of-the-art deep learning techniques to consistently identify regulatory elements at a genome-wide scale from massively heterogeneous data across diverse cell types/tissues. 0
Introduction
Enhancers are distal cis-acting DNA regulatory elements that play key roles in controlling cell type-/tissue-specific gene expression [1] [2] [3] [4] . In higher eukaryotes, enhancers recruit transcription factors (TFs) and cofactors to orchestrate vital biological processes including development and differentiation 5, 6 , maintenance of cell identity [7] [8] [9] , response to stimuli [10] [11] [12] , and interactions with target genes through promoter-enhancer looping [13] [14] [15] [16] . Genetic variation or disruption in enhancers is closely associated with diseases and cancers 17, 18 . Although enhancers have long been recognized for their importance in gene regulation and disease, the absence of common sequence features, their distal location from target genes, and their high cell type/tissue specificity have made them challenging to systematically and precisely identify.
The first genome-scale efforts to identify enhancers were based on evolutionary sequence conservation [19] [20] [21] [22] because regulatory sequences are likely to evolve under negative evolutionary selection [23] [24] [25] . Owing to the remarkable advances in next-generation sequencing (NGS) technologies, several high-throughput experimental technologies have been developed to predict enhancers in a genome-wide manner. These approaches involve mapping the binding sites of enhancer indicative transcription factors (TFs) [26] [27] [28] [29] or cofactors [30] [31] [32] by ChIP-Seq, identifying open chromatin with techniques such as DNase-Seq [33] [34] [35] , and interrogating covalent histone modifications by ChIP-Seq 7, 12, 36, 37 . Given the diversity and complexity of these high-throughput data, several computational approaches using supervised or unsupervised machine-learning (ML) algorithms have been developed for genome-wide enhancer prediction. Chromia 38 uses a hidden Markov model (HMM) to predict regulatory elements, CSI-ANN 39 introduces an artificial neural network (ANN) approach, RFECS 40 uses random forests to discriminate enhancers from non-enhancers, and DELTA 41 uses an adaptive boosting (AdaBoost) approach.
ChromaGenSVM 42 , EnhancerFinder 43 and DEEP 44 are all based on support vector machine (SVM) classifiers. The unsupervised learning approaches, ChromHMM 45 and Segway 46 , offer genomic segmentation and characterization based on an HMM and a dynamic Bayesian network, respectively.
Although these ML-based computational approaches have achieved remarkable advances in genome-wide identification of enhancers, there remain some critical issues to be settled. First, some of the current computational approaches are limited by a small number of training set samples; thus, they are unlikely to produce a useful general classifier. Second, most of the computational approaches use merely data derived from histone modification marks. Chromia 38 , CSI-ANN 39 , RFECS 40 , DELTA 41 , ChromaGenSVM 42 , and DEEP-ENCODE 44 combine different numbers and combinations of histone modification marks to predict enhancers. These methods have achieved some success in identifying thousands of enhancers in the human genome. However, it remains a challenging task for these approaches to systematically and precisely predict enhancers, given the simplicity of features derived from only one type of data and the limited number of chromatin modifications that have been examined. Additionally, it is infeasible to fully capture an exhaustive catalogue of chromatin modifications at enhancers. EnhancerFinder 43 tackles this issue by simultaneously integrating diverse types of data instead of using a single type of data, thereby improving its developmental enhancer predictions. Third, the class imbalance problem in which the number of enhancer classes is much smaller than the number of non-enhancer classes is extremely common in predicting enhancers 39, 40, 42, 44 , and ignoring this problem will result in a bias towards the non-enhancer class.
RFECS 40 , DELTA 41 and DEEP 44 based on the learned model derived from one cell type/tissue. Regarding the former strategy, this approach is time-consuming and sometimes infeasible given the data availability of training sets for each cell type/tissue, whereas the latter strategy relies on a universal model derived from single cell type/tissue data to effectively identify enhancers in all other cell types/tissues. DEEP-ENCODE 44 alleviates this problem by combining four cell-specific models containing 4,000 (4 × 1,000) classifiers in total, and it achieved performance consistency across two other cell lines. However, this is far from sufficient as there exist hundreds and thousands of cell lines and tissue types.
To address these fundamental challenges, we developed a deep learning-based algorithmic framework named PEDLA, which is capable of learning an enhancer predictor that integrates massively heterogeneous data and generalizes in ways that are mostly consistent across various cell types/tissues. We used 1,114-dimensional features in total derived from nine categories of heterogeneous data to predict enhancers in H1 cells. The results show that our PEDLA method has three key advantages: limitless training samples, integration from massively heterogeneous data, and the embedded capability of handling highly class-imbalanced data in an unbiased way. Due to these factors, PEDLA shows state-of-the-art performance relative to five existing methods. Furthermore, we extended PEDLA to iteratively learn from 22 training cell types/tissues from the ENCODE Project 47 and the Roadmap Epigenomics Project 48 . The learned optimal model manifested superior classification performance and significant performance consistency in 22 training cell types/tissues and another 20 independent cell types/tissues. Together, our results illustrate the power of harnessing state-of-the-art deep learning techniques to consistently identify regulatory elements on a genome-wide scale from massively heterogeneous data across diverse cell types/tissues.
Results

Prediction of enhancers using PEDLA with heterogeneous signatures
To systematically and precisely predict enhancers on a genome-wide scale, we developed a deep learning-based algorithm framework named PEDLA (see Materials and Methods, Fig. S1 ). Briefly, we first used nine categories of heterogeneous data in H1 cells that serve as discriminating features to identify enhancers, including histone modifications (ChIP-Seq), TFs and cofactors (ChIP-Seq), chromatin accessibility (DNase-Seq), transcription (RNA-Seq), DNA methylation (RRBS), CpG islands, evolutionary conservation, sequence signatures, and occupancy of TFBSs. In total, 1,114-dimensional features were used in the training and testing of PEDLA (Table   S1 ). Then, we constructed the enhancer class (positive class set) containing 5,870 enhancer regions (Table S2 ) based on H3K27ac peaks in the H1 cell line as no 'gold standard' set of enhancers has been experimentally verified across various cell types/tissues. Next, we maintained a ratio of 1:10 between positive and negative samples by choosing an equal number of promoters and nine times the number of random background regions that were not annotated as promoters or enhancers as the non-enhancer class (negative class set). Finally, we optimized the structure of PEDLA by selecting the most optimal model, which consists of two hidden layers with each layer including 500 hidden units, in terms of accuracy using 5-fold cross-validation in both the training set and test set ( Fig. 1A , Table S3 ). On average, PEDLA achieved 97.7% accuracy, a 97.2% GM (96.6% sensitivity and 97.9% specificity) and an 88.7% F1-score (96.6% recall and 82.1% precision) for the training set, as well as 97.7% accuracy, a 97.0% GM (96.2% sensitivity and 97.8% specificity) and an 88.3% F1-score (96.2% recall and 81.7% precision) for the independent test set. These results demonstrated the superior performance and outstanding robustness of PEDLA in both the training and test sets, suggesting that PEDLA has great representational power for heterogeneous data and excellent ability to solve the overfitting problem.
Ability to handle class-imbalanced data in an unbiased manner
To resolve the class imbalance problem, our PEDLA method has an embedded mechanism in which the prior probability P of each class, which reflects the imbalance of the class data, is directly estimated from the training data. Dividing the posterior probability by the prior probability ܲ can fundamentally eliminate class-imbalanced influence (see Materials and Methods, Fig. S1 ). Thus, for PEDLA, we need to train only a single model instead of combining multiple trained classifiers as ensemble approaches do, which generally results in a bloated structure model. To assess the performance of PEDLA in resolving this issue, we maintained the number of enhancers, promoters and random regions not annotated as promoters or enhancers in the training set of the H1 cell line at 1 : 1 : x (x = 1, 2, …, 9) , such that the ratio between positive and negative samples was 1 : (1 + x). Three performance indicators, namely sensitivity, specificity and GM, which were reported to be suitable for assessing highly imbalanced data sets, were measured using 5-fold cross-validation based on the optimal model of PEDLA with all 1,114-dimensional features ( Fig.   1C -D). For comparison, we additionally developed a classic DNN algorithm and assessed the performance of the classic DNN in resolving this challenge by measuring the three performance indicators ( Fig. S2 ). We found that for PEDLA, all three performance indicators were unbiased for different degrees of imbalance of the class-imbalanced data in both the training and test data. Notably, the performance of PEDLA even showed a certain degree of improvement with increasing imbalance. In contrast, for the classic DNN, the sensitivity and GM performance indicators decreased rapidly as the specificity increased slightly with increasing imbalance of the class data. The higher specificity and the lower sensitivity achieved by the classic DNN for highly class-imbalanced data suggested that the classic DNN tended to be biased towards the majority class, which is similar to the individual SVM for imbalanced data 49 . These results indicate that PEDLA manifested greater capability in resolving the class imbalance problem.
Validation of predicted enhancers
To validate the predicted enhancers using PEDLA, we calculated the validation rate as the percentage of predicted enhancers overlapping with experimental data of enhancer markers, including distal DHSs, p300 binding sites and a few sequence-specific TFs known to function in H1 cells, such as NANOG, OCT4 and SOX2 (see Materials and Methods). Additionally, we computed the misclassification rate as the percentage of predicted enhancers overlapping with annotated promoters (see Materials and Methods). In human H1 cells, we identified 20,689 enhancers using the trained PEDLA with optimal structure, and we found that 42.3%, 16.8%, and 32.4% of these predicted enhancers overlapped with distal DHSs and binding sites of p300 and TFs, respectively. With 10,000 iterations of random shuffling of the enhancer predictions in the H1 genome, we found the average validation rate of distal DHS, p300 and TF to be 13.0%, 1.1% and 4.2%, respectively, and the actual validation rates were highly significant according to a one-sided t-test (p-values = 0) ( Fig. 1B) . Additionally, we found that 6.6% of enhancer predictions overlapped with TSSs annotated by GENCODE (V15) 50 , indicating a low misclassification rate.
These results demonstrate that PEDLA can accurately predict putative enhancers based on the nine categories of heterogeneous data.
Performance comparisons of PEDLA with existing methods
Next, we compared our enhancer predictions with those identified by five state-of-the-art methods, including the supervised learning methods CSI-ANN 39 , RFECS 40 , and DELTA 41 and the unsupervised learning methods ChromHMM 45 and Segway 46 , in H1 cells. The optimal model of CSI-ANN was obtained based on 39 histone modifications from CD4+ T cells 39 , the best model of RFECS was derived from the profiles of 24 histone modifications in H1 and IMR90 cells 40 , whereas the optimal model of DELTA was trained on the optimal subset of histone modifications derived from H1 and CD4+ T cells 41 . To make a fair comparison of performance of our method with those of the three supervised approaches, we applied PEDLA and the three supervised learning methods to a common histone modification dataset in H1 cells. For the common dataset, we used H3K4me1, H3K4me3 and H3K27ac as the minimal chromatin marks for enhancer prediction as these three histone markers were previously used as the minimal subset of histone modifications to predict enhancers by both CSI-ANN 39 and RFECS 40 and were also ranked within the top 4 in terms of variable importance in DELTA in H1 cells 41 . Using these three histone markers in H1 cells, RFECS, CSI-ANN, and DELTA made 75,084, 30,173, and 112,044 enhancer predictions, respectively, based on the optimal parameters and default threshold used in their studies. PEDLA yielded 22,691 enhancers using the optimal structure of a hidden layer with 50 hidden units determined by 5 We compared PEDLA with the five existing methods based on nine performance indicators: accuracy; sensitivity; specificity; GM; F1-score; validation rates of distal DHSs, P300, and TFs; and misclassification rate. The comparative analysis across these methods is summarized in Table 1 . Based on the performance indicators accuracy, sensitivity, GM, F1-score, and validation rate (DHS, P300, and TFs), PEDLA consistently performed better than all other methods. Based on specificity, two unsupervised methods (ChromHMM and Segway) were ranked first followed by CSI-ANN, RFECS, PEDLA and DELTA. Based on misclassification rate, DELTA and RFECS shared the best results, followed by ChromHMM, PEDLA, Segway and CSI-ANN. Furthermore, comparing PEDLA of the optimal model based on the three minimal chromatin marks with that based on the full 1,114 features, we found that PEDLA of full features consistently performed better than PEDLA of the three minimal chromatin marks for all performance indicators. This result suggests that approaches integrating diverse types of data give more complete and precise representation of enhancers and thus can significantly improve enhancer prediction compared to methods using only a single type of data.
Because the different performance indicators illustrate the distinct advantages and disadvantages of these studied methods, we ranked their performance according to the nine metrics. In total, we performed nine different tests, including seven methods and nine performance indicators. According to a previously published method 51 , we averaged the ranked positions of each of the seven methods used in comparison in all nine tests. Table 2 demonstrates the overall score and average rank position of each of the methods; a lower average rank indicates better performance. This analysis revealed that across the different performance tests, the PEDLA with both full signature sets and three minimal chromatin marks shared the best results, followed by CSI-ANN, ChromHMM, RFECS, DELTA and Segway.
Further performance assessment across methods
To further assess the performance across these supervised methods, we should exclude the bias of different numbers of enhancer predictions of these methods on performance comparison. Thus, we selected thresholds that yielded comparable numbers of predictions for RFECS, CSI-ANN, and DELTA, so as to make a fair comparison across these methods. We obtained 20,595, 19,859, and 20,679 enhancer predictions for RFECS, CSI-ANN, and DELTA, respectively, which were comparable to the number of predictions obtained by our PEDLA, 22,691 ( Table 3 ). Comparing with the data presented in Table 1 , we found that the three methods achieved higher validation rate and lower misclassification rate, but they obtained a much lower accuracy. Most importantly, the sensitivity, GM and F1-score of these three methods decreased rapidly. These results suggested that the performance comparison analysis at comparable numbers of predictions across these methods seems fair, however, such analysis might deflate the performance of the three methods in some cases. Solely comparing performance at similar numbers of enhancer predictions across methods might sacrifice the balance between different performance indicators.
All the trainings of these supervised methods were based on a positive enhancer set (5,870 enhancer regions, Table S2 ) that were constructed by calling H3K27ac peaks in the H1 cell line using MACS 52 with a stringent significance level (p-value < 10 -9 ).
To test whether the positive enhancer set has effects on the performance assessment of these methods, we constructed two independent positive enhancer sets by calling H3K27ac peaks using two less stringent significance levels (p-value < 10 -6 and p-value < 10 -4 ). We obtained 8,413 and 11,937 enhancers as positive set, and re-trained the models of these methods with these two less stringent training sets, respectively. We summarized the results of performance assessment across methods in Table 4 and Table S6 , respectively. Our results suggested that in both cases, our PEDLA achieves much better performance relative to other methods. To further strengthen our finding, we re-trained the models of these methods with the positive enhancer set provided by the study of RFECS 40 , which consists of 5,899 active and distal p300 binding sites ( has to combine many cell type-/tissue-specific models, which makes the structure of DEEP-ENCODE more bloated.
Inspired by the core idea of deep learning using unsupervised pre-training followed by supervised fine-tuning, we developed an iterative PEDLA for enhancer prediction across diverse human cells and tissues to resolve the above-mentioned issues. To explore the effectiveness of PEDLA to predict enhancers in multiple cell types/tissues, we selected 22 cell types/tissues from the ENCODE Project 47 (Table S5) , which was assessed using R package called randomForest 53 . We recorded the three performance indicators (accuracy, GM, and F1-score) across these cell types/tissues, which made it intuitive to interrogate the dynamic performance of PEDLA with the increasing number of cell types/tissues that it had been trained on. We found that the mean values of the performance indicators increased and that the variances of the performance indicators decreased with an increasing number of training cell types/tissues, suggesting that increased performance and increased consistency were obtained for of our PEDLA enhancer predictions, respectively. Furthermore, the three performance indicators increased rapidly when the second cell type/tissue was added into the training, indicating that the performance and consistency of PEDLA were greatly improved compared to the performance and consistency of the PEDLA that was trained on only one cell type/tissue. After finishing the training of the five cells/tissues, the performance indicators remained unchanged, suggesting that the performance and the consistency of PEDLA were stable at this stage.
We use the best-trained model of PEDLA that had been completed using the training on all 22 training cell types/tissues to further assess its generalizability using the three performance indicators ( Fig. 4 ; Table S7 in enhancer prediction, further suggesting its superior performance consistency across various cell types/tissues.
Comparison with the DEEP-ENCODE model
To further illustrate the performance superiority and generalization capabilities of our PEDLA in multiple human cell types, we re-trained and re-tested our PEDLA using the training and testing sets of DEEP-ENCODE model 44 
Discussion
In this study, we developed a deep learning-based algorithmic framework named PEDLA (https://github.com/wenjiegroup/PEDLA) to systematically and precisely predict enhancers on a genome-wide scale using heterogeneous types of data. PEDLA has three outstanding characteristics that make it ideal for achieving state-of-the-art performance relative to five existing methods for enhancer predictions. First, PEDLA is capable of learning an enhancer predictor based on massively heterogeneous data to fully capture the universal patterns of enhancers, which makes its enhancer predictions more comprehensive and accurate. In H1 cells, we trained PEDLA using 1,114-dimensional heterogeneous features and 811,036 training samples and demonstrated that PEDLA has three key advantages: limitless training samples, integration of massively heterogeneous data, and an embedded ability to handle highly class-imbalanced data in an unbiased way ( Fig. 1 ). All these merits make PEDLA a general and robust deep learning-based framework for enhancer predictions.
Second, PEDLA can generalize enhancer predictions in ways that are mostly consistent across various cell types/tissues. We extended PEDLA to iteratively learn from multiple cell types/tissues, which is motivated by the core idea of deep learning that uses unsupervised pre-training as initialization of the subsequent supervised fine-tuning. The whole training procedure of PEDLA in multiple cell types/tissues consists of initial training and iterative training (Fig. 2) . The initial training procedure adopts a traditional deep learning strategy, whereas the iterative training procedure uses the trained optimal model parameters of a previous cell type/tissue as initialization for the supervised fine-tuning of a subsequent cell type/tissue iteratively.
We applied PEDLA to iteratively train on 22 training cell types/tissues, and we found that the learned optimal model manifested superior predicting performance and significant performance consistency in 22 training cell types/tissues and another 20 independent cell types/tissues ( Figs. 3-4 ).
Third, PEDLA is capable of extending to input data of any type and to predictions of any type of functional element/domain. Our PEDLA used nine categories of heterogeneous data in H1 cells as discriminating features to identify enhancers. In fact, any type of data that consists of real values can be served as input features to PEDLA.
Additionally, the numbers of input features can range from a few to thousands.
Furthermore, PEDLA can be trained on training sets of any number of cell types/tissues but will not result in bloated structures. Most importantly, provided with prepared suitable feature data and constructed accurate positive and negative sets for the task, PEDLA can be extended with almost no modifications to identify any types of functional elements/domains, including promoters, insulators, and repressors.
In our recent study, we presented a novel method, DNN-HMM, for the de novo identification of replication domains 54 . We adopted DNN-HMM model as one unit of our PEDLA. Comparing with DNN-HMM that identified replication timing domains using only Repli-seq data, PEDLA identified enhancers using nine categories of heterogeneous data. Additionally, we illustrated the excellent capability of PEDLA in handling class-imbalanced data unbiasedly, which is a key challenge in enhancer prediction. Furthermore, PEDLA was a flexible framework which could be trained on any number of cell types/tissues and achieved superiorly consistent performance across various cell types/tissues in enhancer prediction. However, DNN-HMM was trained in one cell type, and used the single-cell-trained model to predict replication timing domains in other cell types.
Although PEDLA achieved state-of-the-art performance in enhancer prediction, there is still room for further improvement. First, we carefully selected 1,114-dimensional features derived from nine categories of heterogeneous data in H1 cells; however, it remains challenging to select the comprehensive and discriminating features to identify enhancers; thus, further optimization of the feature set must be continued.
Additionally, all these features used by PDELA are two-dimensional (2D). It is expected that integrating three-dimensional (3D) structure information derived from 5C, Hi-C, ChIA-PET and Capture-C will greatly improve the prediction of enhancers,
given that 3D chromatin structure is increasingly considered an important regulator of gene expression and that enhancers regulate target genes through promoter-enhancer looping 55, 56 . A recent study combined Hi-C data with phylogenetic correlations to predict the target genes of distal regulatory elements, such as enhancers, repressors, and insulators 57 . Another group demonstrated that modelling Hi-C data with their computational method, called graph-based regularization (GBR), greatly improved the prediction of replication and topological domains 58 . These studies inspired us to further improve PEDLA through the incorporation of 3D structure information.
Second 
Materials and Methods
Feature data
For the construction of PEDLA to predict enhancers in H1 cells, we used nine sets of (Table S1 ). 
Data normalization for diverse data types
Construction of the positive and negative sets
Considering that there are no 'gold standard enhancers' that have been experimentally verified across various cell types/tissues, we constructed the enhancer set (positive set) using histone marker H3K27ac, which is viewed as an active enhancer hallmark 9, [68] [69] [70] and is ubiquitously available across dozens of cell types/tissues. To construct the positive set, we started from the candidate H3K27ac peaks called by MACS 52 with a p-value < 10 -9 for each replicate independently. Then, we selected the candidate H3K27ac peaks that were consistently identified in multiple replications. Next, we strictly used the highly reliable H3K27ac peaks, which met the following criteria as described previously 10 : (1) H3K27ac peaks that were located within 1 kb of all annotated transcription start sites (TSSs) of protein-coding genes annotated by GENCODE (V15) 50 were removed. (2) H3K27ac peaks that had a 5'-sequenced expressed sequence tag (EST) with a 5' end within 2 kb of the H3K27ac peak and spanning an annotated TSS were removed on the basis of annotations of ESTs from the UCSC Genome Browser spliced EST track. (3) H3K27ac peaks that had significant enrichment of both H3K4me1 and H3K4me3 in a 2-kb window centred on the peak were removed. (4) H3K27ac peaks with significant enrichment of H3K4me3 within a 2 kb window centred on the peak were also removed. (5) An H3K4me1 peak had to be present within 2 kb of the H3K27ac peak. (6) The H3K27ac peak had to be at least 2 kb away from all rRNA genes.
Non-enhancers (the negative data set) contained an equal number of promoters and x times the number of random genomic loci not annotated as promoters or enhancers.
Promoters are defined as 2-kb regions centred on TSSs of protein-coding genes, and random genomic loci were generated with an equivalent length distribution as enhancer regions. For each learning set, we set x = 9 to maintain a ratio of 1:10 between positive and negative samples, which is consistent with previous studies 39, 40, 42, 44 . In the analysis of class imbalance problems, we changed x from 1 to 9. 
Training the PEDLA for enhancer predictions
Enhancer prediction with PEDLA, which follows our recently reported method 54 , involved two stages, namely training and prediction procedures (Fig. S1 ).
1. Training procedure 1) Read the normalized features and annotated labels as input data.
2) Estimate the initial state probability vector ߨ and state transition probability matrix ‫ܣ‬ of HMM.
3) Pre-train the DNN layer-by-layer in an unsupervised fashion, then use the pre-training as initialization to fine-tune the weight matrix ܹ of the DNN using mini-batch gradient descent in a supervised manner. 
4) Estimate the prior probability vector
ܲ ൌ ൛ ‫‬ ൫ ‫ݍ‬ ௧ ൌ ܵ ൯ ൟ ൌ ൛ ݊ ൫ ܵ ൯ ݊ ⁄ ൟ , where ݊ ൫ ܵ ൯ is
Performance assessment of PEDLA
Our PEDLA employed a threshold-free decision mechanism and could automatically make the optimal decision to output the most reasonable enhancer predictions. The threshold-dependent receiver operation curves (ROCs) and corresponding the area under the curve (AUC) cannot used to assess the performance of PEDLA. To compare the performance across these methods, we computed the following three performance indicators used in our recent study 54 .
where TP indicates true positives, FP indicates false positives, TN indicates true negatives, FN indicates false negatives, and
where GM is the geometric mean of sensitivity and specificity, Sensitivity = TP/(TP+FN) and Specificity = TN/(TN+FP), and
where the F1 score is the harmonic mean of recall and precision, Recall = Sensitivity and Precision = TP/(TP+FP).
For PEDLA and other supervised methods, we used 5-fold cross-validation to obtain unbiased estimates of the three performance indicators. For the unsupervised methods, ChromHMM and Segway, we obtained these three performance indicators by comparing their enhancer predictions with the labels of the positive and negative sets.
Selecting optimal structure of PEDLA
To determine the optimal structure of hidden layers for PEDLA, we tuned the structure of hidden layers by fixing the number of hidden layers to 1 or 2 and the number of hidden units in each hidden layer to 10, 50, 100 or 500. We made enhancer predictions using PEDLA for diverse structures that are composites of various hidden 3 0 layers and hidden units of each layer. We computed the three performance indicators using 5-fold cross-validation and compared them between the structure models of PEDLA to select the optimal structure model of PEDLA in terms of accuracy (Table   S3 ). 47 , and p300, NANOG, OCT4 and SOX2 binding sites were obtained from a recent study 40 . For Hela-S3 and K562 cell lines, DHSs and p300 were obtained from the study of DEEP 44 . TSS annotations were extracted from the GENCODE annotations (V15) 50 . Predicted enhancers overlapping with a window of -100 to +100 bp centred at a distal enhancer marker that was greater than 5 kb away from the nearest TSS were classified as ''validated'', whereas predicted enhancers located within 2.5 kb of a TSS were classified as ''misclassified''. Input data A 1. Initial training 1) Read the normalized features and annotated labels of cell type/tissue 1.
Validation of enhancer predictions
Figure legends
2) Estimate the initial state probability vector and state transition probability matrix of HMM. 3) Pre-train DNN layer by layer unsupervisedly, and then use the pre-training as initialization to fine-tune the weight matrix of DNN using mini-batch gradient descent in a supervised manner. 4) Estimate the prior probability vector . 2. Iterative training 1) Read the normalized features and annotated labels of cell type/tissue 2,3,4, ⋯ . 2) Fetch the trained model parameters , , , of a previous cell type/tissue as initialization. 3) Update the initial state probability vector and state transition probability matrix of HMM. 4) Use as initialization to refine the weight matrix of DNN using mini-batch gradient descent in a supervised manner. 5) Re-estimate the prior probability vector . 6) Go to step 1 of the iterative training procedure and set 1 if there is input data of another new cell type/tissue; Otherwise output the final optimal model parameters that have been trained on all cell types/tissues and exit. 
